Connection
Co-Authors
This is a "connection" page, showing publications co-authored by Steven Gitelis and Marta Batus.
|
|
Connection Strength |
|
 |
|
 |
|
0.432 |
|
|
|
-
Gusho CA, Weiss MC, Lee L, Gitelis S, Blank AT, Wang D, Batus M. The clinical utility of next-generation sequencing for bone and soft tissue sarcoma. Acta Oncol. 2022 Jan; 61(1):38-44.
Score: 0.219
-
Fice M, Almajnooni A, Gusho C, Chapman R, Mallikarjunappa S, Batus M, Gitelis S, Colman M, Miller I, Blank A. Does synovial sarcoma grade predict oncologic outcomes, and does a low-grade variant exist? J Surg Oncol. 2022 Jun; 125(8):1301-1311.
Score: 0.056
-
Lee L, Kazmer A, Colman MW, Gitelis S, Batus M, Blank AT. PET-CT staging affects time to treatment in sarcoma. Surg Oncol. 2022 May; 41:101732.
Score: 0.056
-
Lee L, Kazmer A, Colman MW, Gitelis S, Batus M, Blank AT. What is the clinical impact of staging and surveillance PET-CT scan findings in patients with bone and soft tissue sarcoma? J Surg Oncol. 2022 Apr; 125(5):901-906.
Score: 0.056
-
Chowdhary M, Sen N, Jeans EB, Miller L, Batus M, Gitelis S, Wang D, Abrams RA. Neoadjuvant Interdigitated Chemoradiotherapy Using Mesna, Doxorubicin, and Ifosfamide for Large, High-grade, Soft Tissue Sarcomas of the Extremity: Improved Efficacy and Reduced Toxicity. Am J Clin Oncol. 2019 01; 42(1):1-5.
Score: 0.045
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|